Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comprehensive assessment of musculoskeletal health in children with cystic fibrosis – search for means of improvement (Phase IIIb)
2022-002330-13Phase 3Active
- Sponsor
- Motol University Hospital
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vitamin d in bone disease, low bone mineral density and musculoskeletal condition (MSK) (2 arms), sponsored by Motol University Hospital. Primary endpoints: Effectiveness of vitamin D substitution on bone metabolism, Bone mineral density and 2 more. Started Jun 2022; status: active.
02
Drugs
vitamin d
03
Conditions
bone diseaselow bone mineral densitymusculoskeletal condition (MSK)
Beyond the preview
Go deeper on 2022-002330-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002330-13.